32nd Congress of the ESP and XXXIII International Congress of the IAP
(Glasgow) 2020: A Vision for the Future
5 - 9 December 2020 | now virtual
ESP website
32nd ESP Congress & XXXIII IAP Congress
Congress
ECP 2019 Nice
Presentations
Sunday, 8 September 2019
Congress
Welcome Address
General Information
Downloads
Related Meetings / Media Partners
Committees & Organiser
CME Accreditation
Congress Newsletter
ECP 2019 Nice
Gallery
Awardees
Industry Partners
Presentations
Sunday, 8 September 2019
Monday, 9 September 2019
Tuesday, 10 September 2019
Wednesday, 11 September 2019
FAQs
Abstracts
Guidelines for Submission
Bursaries
Format Descriptions
Registration
Registration Fees
Scientific Programme
Scientific Contents
Molecular Pathology Diagnostics Symposium
Computational Pathology Symposium
Sponsors & Exhibitors
General Information
Acknowledgements
My Account
Create Account
Congress Account
Sunday, 8 September 2019
Monday, 9 September 2019
Tuesday, 10 September 2019
Wednesday, 11 September 2019
Sunday, 8 September 2019
08:30 - 12:00
CP-01 | Computational Pathology Symposium - Morning Session
CP-01-001-Clinical-grade artificial intelligence: hype or hope for cancer care
CP-01-003-Building an AI school for pathology: workflow for Human-AI interfaces
LC-01 | Head and Neck Pathology: High quality reporting of head and neck cancers
LC-01-001-Introduction to ICCR - reporting of nasopharyngeal and oropharyngeal carcinomas
LC-01-002-Reporting of oral cavity carcinomas
LC-01-003-Reporting of carcinomas of the larynx and hypopharynx
LC-01-004-Reporting of salivary gland carcinomas
LC-01-005-Reporting of carcinomas of the nose and paranasal sinuses
LC-01-006-Reporting of neck dissection specimens
OFP-01 | Joint Session: Uropathology / Nephropathology
OFP-01-001-The influence of the presence of intraductal carcinoma of the prostate on the grade group systems prognostic performance
OFP-01-003-A new auto-annotation method and machine learning strategy for detection and annotation of cancer areas in prostate biopsies
OFP-01-004-Detection of PD-L1 RNA expression in immunohistochemically negative patients. Are the negatives a heterogenous group?
OFP-01-006-Intra and interpatient genetic features of intraductal carcinoma of the prostate
OFP-01-007-Papillary Renal Cell Carcinoma with prominent spindle cell stroma - tumour mimicking MESTK , clinicopathologic analysis of 5 cases
OFP-01-008-TFEB-amplified renal cell carcinoma: a comprehensive study of 7 novel cases
OFP-01-009-Improvement of vascular invasion scoring in stage I testicular non-seminomas to predict relapse during surveillance after orchiectomy
OFP-01-012-Immune cell infiltration in pediatric renal allografts: mononuclear phagocytes correlate with rejection, re-transplantation and fibrosis in a retrospective study
OFP-02 | Digestive Diseases Pathology - GI
OFP-02-001-Risk factors for intraductal tumour spread of submucosal gland in early squamous cell neoplasia: analysis of endoscopically resected specimens
OFP-02-002-Site of residual esophageal cancer after neo-adjuvant chemoradiotherapy with regard to the anatomical layers and radiation target volumes at histopathologic examination
OFP-02-003-Mechanotransduction in mice colon tumourigenesis : a pathologically reactivated physiological embryonic mechanosensitive pathway
OFP-02-004-The prognostic impact of the colorectal cancer microenvironment components and their spatial relationships
OFP-02-005-Cell line-derived xenografts: a possible in vivo model to investigate tumour budding in colorectal cancer
OFP-02-006-Comprehensive molecular analysis of recurrence in gastrooesophageal adenocarcinoma
OFP-02-008-Histopathological and molecular features of adenomatous and serrated colon adenomas, characteristics and overlapping features, challenges in the nomenclature
OFP-02-009-How many biopsies are needed to assess the Peritoneal Regression Grading Score (PRGS) in peritoneal metastasis?
OFP-02-011-Are tumor budding and tumor grade the same in colorectal cancer?
OFP-02-012-Expression of the inhibitory receptor CD94/NKG2A on CD8+ tumour-infiltrating lymphocytes in colorectal cancer: a new promising druggable immune checkpoint in a context of HLA-E/b2microglobuline overexpression by tumour cells
OFP-02-013-E-learning for instruction of scoring the tumour-stroma ratio (TSR) in colon carcinoma amongst international pathologists, as part of the UNITED study.
OFP-02-014-For better or worse: clinical correlation of SOX9 expression in irradiated rectal cancer
SPEC-01 | French Society of Pathology: Molecular pathology practice in Europe: how we do it
SPEC-01-001-Molecular pathology practice in Europe: an overview
SPEC-01-002-Molecular pathology practice in Germany
SPEC-01-003-Molecular pathology practice in the United Kingdom
SPEC-01-005-Molecular pathology practice in Spain
SPEC-01-006-Molecular pathology practice in Sweden
SPEC-01-007-Molecular pathology practice in France
SY-01 | Breast Pathology: New ideas in breast pathology (+Business Meeting)
SY-01-001-Invasive or not?
SY-01-004-Lobular carcinomas: not a single molecular entity
SY-02 | Gynaecological Pathology: New developments in cervical pathology
SY-02-002-Lower genital tract squamous neoplasia: classification, markers and recommendations
SY-02-004-NHPVA types of endocervical adenocarcinomas
SY-02-005-Update on adenosquamous lesions of the cervix: precursors and invasive carcinoma
SY-02-006-Update on reporting and issues in staging cervical cancer
SY-03 | Molecular Pathology: Proteomics (+Business Meeting)
SY-03-001-Proteomics of FFPE samples
SY-03-002-Cancer proteomics
SY-03-003-MALDI Imaging in pathology
VM-01 | Joint Session Cytopathology / Pulmonary Pathology: When cytology is more useful than histology
VM-01-001-Case 1
VM-01-002-Case 2
VM-01-004-Case 4
12:15 - 13:00
KL-01 | Keynote Lecture by Michael Middleton
KL-01-001-Imaging and pathology
14:45 - 16:45
CP-02 | Computational Pathology Symposium - DPA Session
CP-02-001-Embracing digital and computational pathology: a calling for pathologists as leaders in precision medicine
CP-02-002-Embedding AI into digital pathology workflows
CP-02-003-Enhancing digital pathology with artificial intelligence
SC-01 | Breast Pathology: Prognostic factors revisited
SC-01-002-Inflammatory breast cancer: the pathologists' perspective
SC-01-004-ASCO/CAP HER2 guidelines update
SC-02 | Head and Neck Pathology: Non-malignant diseases of the head and neck: in memory of Leslie Michaels
SC-02-003-Update on squamous intra-epithelial lesions of the larynx
SC-02-005-IgG4 related diseases of the head and neck
SS-01 | Gynaecological Pathology: Diagnostic mistakes in gynaecological pathology
SS-01-001-Case 1
SS-01-003-Case 3
SS-01-004-Case 4
SS-01-005-Case 5
SS-01-006-Case 6
SY-04 | Digestive Diseases Pathology: Microsatellite instability in tumours of the digestive tract: from bench to bedside
SY-04-003-Microsatellite instability testing: which analysis in routine practice for the pathologist?
SY-04-004-The next generation of microsatellite instability testing
SY-04-005-Immunotherapy in metastatic colo-rectal cancer (mCRC): the potential of immune checkpoint inhibitors
SY-05 | Joint Session Infectious Diseases Pathology / Molecular Pathology: Cancer and the microbioma
SY-05-001-Fusobacterium and colorectal cancer: fact or myth
SY-05-004-Panel Discussion: Cancer & microbiome - will the new knowledge impact future diagnostic pathology
SY-06 | Nephropathology: Mechanisms in renal diseases (+Business Meeting)
SY-06-005-Complement mediated glomerulopathies
VA-01 | Highlights of Virchows Archiv Annual Review 2020: what is new in soft tissue tumours?
VA-01-002-What is new in epithelioid soft tissue tumours?
VA-01-003-What is new in adipocytic neoplasia?
VA-01-006-What is new in the immunohistochemical and molecular genetic study of selected aspects of soft tissue tumours?
17:15 - 19:15
CP-03 | Computational Pathology Symposium - Evening Session
CP-03-000-Intro
CP-03-001-Deep learning enables fully automated mitotic density assessment in breast cancer histopathology
CP-03-002-Automated grading of urothelial cell carcinoma of the bladder
CP-03-003-Unsupervised anomaly detection: application to colorectal liver metastasis
CP-03-004-Automated Ki67 hot-spot detection and analysis leads to higher Ki67 proliferation indices
CP-03-005-U-Net ensembles for accurate classification of oesophageal adenocarcinoma
CP-03-006-Artificial intelligence driving automated pathology: iCAIRD and beyond
OFP-03 | Cytopathology
OFP-03-001-Negative ThyroSeq® genomic testing for indeterminate thyroid nodules: the memorial sloan kettering cancer center experience
OFP-03-002-Ultrasound guided fine needle aspiration of thyroid: inadequacy rate with rapid on site evaluation
OFP-03-004-The value of fine needle aspiration cytology in the examination of parathyroid lesions; role of immunocytochemistry and washout fluid analysis
OFP-03-006-BRAF mutation prediction from metastatic melanoma cytological smear using deep learning: an ongoing project
OFP-03-007-Metabonomics profiling of malignant peritoneal effusion with 1H-NMR spectroscopy
OFP-03-009-Correlation between the ultrasound-guided thyroid fine-needle aspiration cytology with molecular testing and surgical histopathology results
OFP-03-011-Contribution of TERT promoter mutation status to preoperative diagnosis of thyroid carcinoma
OFP-03-012-Thyroid nodules with AUS/FLUS cytology: what happens next?
SC-03 | Joint Session Gynaecological Pathology / Uropathology: Tumours of the ovary and testis: an update
SC-03-001-Small cell carcinoma of the ovary of hypercalcaemic type: unravelling the mysteries of a tumour unique to the ovary
SC-03-002-Differential diagnosis of ovarian mucinous tumours
SC-03-003-Ovarian Sertoli-Leydig cell tumours
SC-03-004-Histologic heterogeneity of seminoma of the testes
SC-03-005-Non seminomatous germ cell tumours of the testes. An update
SS-02 | Joint Session Breast Pathology / Infectious Diseases Pathology: Infections of the breast
SS-02-001-Case 1
SS-02-002-Case 2
SS-02-003-Case 3
SS-02-004-Case 4
SS-02-006-Case 6
SS-03 | Head and Neck Pathology: Challenging diagnostic problems in head and neck pathology
SS-03-003-Case 3
SS-03-005-Case 5
SS-03-006-Case 6
SS-03-007-Case 7
SY-07 | Molecular Pathology: Molecular morphology
SY-07-001-New developments of in situ methods
SY-07-004-Immunohistochemistry in clinical research
SY-08 | Nephropathology: Renal transplant pathology: the French perspective
SY-08-005-i-IF/TA
SY-09 | Pathology in Favour of Developing Countries: Pathology in developing countries: from real-life experiences to expectations for a better future
SY-09-001-Pathology in the Horn of Africa: the APOF project in Somaliland
SY-09-002-Prevention and diagnosis of breast cancer in a conflict area: the experience in Herat, Afghanistan
SY-09-003-Pathology services in a low resource setting: University of Abuja Teaching Hospital, Abuja, Nigeria experience
SY-09-005-The many roads to diagnosis of tuberculosis: experience of a tertiary care centre in southwest coastal India
SY-09-006-Cytology as a tool in diagnosis of toxoplasma